Current Targeting of Malaria

Drugging of Malaria

In GLScienceBrain: Drugs to fight Malaria

Drugs in Development

38835069 /24

Similar Story as ours: 31467193

Keltic Pharma – Transforming malaria treatments / initially funded by European Union Malaria Fund (EUMF) / Andrew Tobin and published in the journal Science, that identified a small molecule inhibitor (TCMDC-135051) of the essential malarial protein kinase PfCLK3 / structure function data: acs.jmedchem

A screen of the GlaxoSmithKline antimalarial-focused chemical library, called the Tres Cantos anti-malarial set (TCAMS), identified the compound TCMDC-135051

Problems with Vaccines:

• kühlkette, boosting, verlust von effizienz, braucht herdenimmunität, heilt nicht
• In December 2024, a mysterious respiratory illness, referred to as "Disease X," emerged in the Democratic Republic of Congo (DRC), causing concern among public health officials. Initial investigations by the World Health Organization (WHO) and the DRC's Ministry of Health suggested that many of the initial samples tested positive for malaria, along with common viral respiratory infections. The outbreak prompted a rapid response from international and national health organizations, including the deployment of teams to investigate and provide support to affected areas. - Resistenzbildung, Selektion

Current meds in development and what chatGPT thinks of them

made by Markus Meissner